| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Rowe Robert Scott | President & CEO, Director | 5215 N. O'CONNOR BLVD., SUITE 700, IRVING | /s/ Shakeeb U. Mir, attorney-in-fact | 17 Feb 2026 | 0001608962 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | FLS | Common Stock | Award | $0 | +194,460 | +56% | $0.000000 | 541,174 | 13 Feb 2026 | Direct | |
| transaction | FLS | Common Stock | Tax liability | $6,658,944 | -76,522 | -14% | $87.02 | 464,652 | 13 Feb 2026 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | FLS | Performance Rights | Award | $0 | +57,034 | +22% | $0.000000 | 312,196 | 12 Feb 2026 | Common Stock | 57,034 | Direct | F1 | |
| transaction | FLS | Restricted Stock Units | Award | $0 | +38,022 | +21% | $0.000000 | 216,976 | 12 Feb 2026 | Common Stock | 38,022 | Direct | F2 | |
| transaction | FLS | Performance Rights | Options Exercise | $0 | -184,264 | -59% | $0.000000 | 127,932 | 13 Feb 2026 | Common Stock | 184,264 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2026 and ending on December 31, 2028 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's average annual earnings per share growth over each calendar year during the performance period. The performance rights are also subject to a 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period, as of January 1, 2026. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. |
| F2 | Each restricted stock unit represents the right to receive, at settlement, one share of common stock and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2026. |
| F3 | Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2023 and ending on December 31, 2025 which are based equally on: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's free cash flow ("FCF") as a percentage of adjusted net income for each calendar year during the performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. |